---

Dr. McCloskey's research focus is on phase I/II non-randomized study of birinapant in combination with decitabine in patients with relapsed or refractory myelodysplastic syndrome and acute myelogenous leukemia, and was a primary investigator of cellular and molecular characterization of the immune response and minimal residual disease in patients who have completed treatment for acute myeloid leukemia.

Send Message